Physician profile
William T Su
NPI 1730105743
$8,715.61
in general payments reported to CMS, 2019-2025
35 companies · $1,094 in 2025
The $1,094 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $901 · 2020: $208 · 2021: $947 · 2022: $1,428 · 2023: $1,941 · 2024: $2,196 · 2025: $1,094.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,523 · Travel and Lodging: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,523.02 |
| Travel and Lodging | $708.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,737.15 | 2019-2024 | Gore Viabahn Endoprosthesis With Heparin, Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Aaa Endoprosthesis |
| Silk Road Medical, INC. | $1,453.34 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Tactile Systems Technology INC | $1,060.35 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Boston Scientific Corporation | $584.87 | 2019-2025 | Enroute Transcarotid Neuroprotection System, Varithena Administration Pack |
| Endologix LLC | $408.81 | 2022-2025 | Alto Abdominal Stent Graft System |
| Bolton Medical INC | $403.99 | 2020-2023 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| Pfizer INC. | $384.18 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $366.03 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $358.28 | 2019-2025 | Eliquis |
| Medtronic, INC. | $322.93 | 2021-2025 | Endurant Iis, Valiant Captivia, Venaseal |
| Philips North America LLC | $307.53 | 2019-2023 | |
| Smith+Nephew, INC. | $264.57 | 2021-2025 | Collagenase Santyl, Stravix, Grafix Pl |
| Cashflow Solutions, LLC | $160.80 | 2023-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Bard Peripheral Vascular, INC. | $134.78 | 2019-2022 | |
| Organogenesis INC. | $94.38 | 2022-2023 | Puraply |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $87.70 | 2023-2024 | Dalvance, Teflaro |
| Angiodynamics, INC. | $84.47 | 2020-2022 | |
| Getinge USA Sales, LLC | $55.49 | 2025 | Flixene |
| Terumo Medical Corporation | $50.51 | 2020-2022 | |
| Lemaitre Vascular, INC. | $44.84 | 2022-2024 | Hydro Lemaitre Valvulotome |
| Astrazeneca Pharmaceuticals LP | $43.33 | 2021 | |
| Sanara Medtech INC. | $40.07 | 2023-2024 | Celleraterx |
| Coopersurgical, INC. | $39.09 | 2022 | |
| Kerecis Limited | $28.60 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Surmodics, INC. | $28.43 | 2023 | Pounce Thrombectomy, Pounce Thrombectomy System, Pounce Venous Thrombectomy System |
| Medtronic Vascular, INC. | $24.27 | 2019 | |
| Becton, Dickinson and Company | $20.22 | 2025 | Covera |
| Paratek Pharmaceuticals, INC. | $18.98 | 2023 | Nuzyra |
| Stryker Corporation | $18.29 | 2022 | |
| Solventum Corporation | $17.66 | 2025 | Kerramax Care, Activ.A.C., 3m Coban |
| Normatec Industries, LP | $16.14 | 2019 | |
| Shockwave Medical, INC | $15.76 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Dova Pharmaceuticals | $14.94 | 2019 | |
| Cardinal Health 200 LLC | $12.83 | 2021 | |
| Penumbra, INC. | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Su listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.